Biogened S.A. (WSE:BGD)
Poland · Delayed Price · Currency is PLN 18.00
0.00 (0.00%)
At close: Mar 26, 2026
Biogened Market Cap
Biogened has a market cap or net worth of 44.21 million as of March 27, 2026. Its market cap has decreased by -21.05% in one year.
Market Cap
44.21M
Enterprise Value
62.14M
Revenue
114.04M
Ranking
n/a
PE Ratio
9.56
Stock Price
18.00
Market Cap Chart
Since August 31, 2011, Biogened's market cap has decreased from 45.77M to 44.21M, a decrease of -3.39%. That is a compound annual growth rate of -0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 44.21M | -16.67% |
| Dec 30, 2025 | 53.06M | -6.09% |
| Dec 30, 2024 | 56.50M | 27.78% |
| Dec 29, 2023 | 44.21M | 41.73% |
| Dec 29, 2022 | 31.20M | 47.67% |
| Dec 30, 2021 | 21.12M | 1.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korbank | 46.65M |
| MakoLab Spólka Akcyjna | 46.46M |
| Prymus | 45.60M |
| Herkules | 44.70M |
| Sygnis | 44.16M |
| Legimi | 43.70M |
| Lokaty Budowlane | 43.40M |
| Quantum software | 42.86M |